• Study Resource
  • Explore Categories
    • Arts & Humanities
    • Business
    • Engineering & Technology
    • Foreign Language
    • History
    • Math
    • Science
    • Social Science

    Top subcategories

    • Advanced Math
    • Algebra
    • Basic Math
    • Calculus
    • Geometry
    • Linear Algebra
    • Pre-Algebra
    • Pre-Calculus
    • Statistics And Probability
    • Trigonometry
    • other →

    Top subcategories

    • Astronomy
    • Astrophysics
    • Biology
    • Chemistry
    • Earth Science
    • Environmental Science
    • Health Science
    • Physics
    • other →

    Top subcategories

    • Anthropology
    • Law
    • Political Science
    • Psychology
    • Sociology
    • other →

    Top subcategories

    • Accounting
    • Economics
    • Finance
    • Management
    • other →

    Top subcategories

    • Aerospace Engineering
    • Bioengineering
    • Chemical Engineering
    • Civil Engineering
    • Computer Science
    • Electrical Engineering
    • Industrial Engineering
    • Mechanical Engineering
    • Web Design
    • other →

    Top subcategories

    • Architecture
    • Communications
    • English
    • Gender Studies
    • Music
    • Performing Arts
    • Philosophy
    • Religious Studies
    • Writing
    • other →

    Top subcategories

    • Ancient History
    • European History
    • US History
    • World History
    • other →

    Top subcategories

    • Croatian
    • Czech
    • Finnish
    • Greek
    • Hindi
    • Japanese
    • Korean
    • Persian
    • Swedish
    • Turkish
    • other →
 
Profile Documents Logout
Upload
Ch1 and 2 student
Ch1 and 2 student

...  Whether or not the drug is a controlled substance and if so which class  Phonetic spelling of name ...
Drug Awareness
Drug Awareness

... • Increased levels of activity and feelings of arousal. • Reduced appetite • Increased heart rate and blood pressure, raising the risk of heart attack – the higher the dose, the greater these effects. • Lowered inhibitions, which can lead to users taking risks that they wouldn’t normally take, such ...
Medications and Alzheimer`s Disease
Medications and Alzheimer`s Disease

... Medications and Alzheimer’s Disease To effectively treat and manage Alzheimer’s disease and related disorders (ADRD), it is necessary to focus on improved care, nutrition, environment and physical health. Problems may also arise from lack of mobility, lack of stimulation (boredom), and social isolat ...
Adverse_Reactions_Slideshow
Adverse_Reactions_Slideshow

... ADR detection methods ...
Current issues and challenges in the development of IP monographs
Current issues and challenges in the development of IP monographs

... It is a reference document for various stockholders like enforcement agency, industry, lab, academic institutions etc. Compliance with IP Standards by drug manufacturing industry assures consumers, patients and healthcare professionals of their quality. ...
New Safe Medicines Faster: A new concept for drug development
New Safe Medicines Faster: A new concept for drug development

... Figure 3. Timeline for drug development Research and discovery has become more effective due to new technologies such as High Throughput Screening, Computational Chemistry, Combinatorial and automated chemistry which have enabled screening of compound libraries for potential effect at a rate per day ...
antibilharzial agents
antibilharzial agents

... Uses: Used for treatment of S. Mansoni. Mechanism of action: It inhibit DNA, RNA and protein synthesis Oxamniquine is biotransformed into inactive 6-carboxymethyl and so 6hydroxymethyl group is important for activity. ...
Upper, Downers & All Arounders
Upper, Downers & All Arounders

... hemp and tobacco to finance the American ...
QA34_6_PregnancyPrescribing
QA34_6_PregnancyPrescribing

... assessment. A medication with the best safety record over time should be chosen over a new medication, unless the safety of a new medication has been clearly established. It is impossible to be sure that any drug is ‘safe’ in pregnancy because it is unethical to conduct the randomised placebo-contro ...
L1: Intro to Pharm- Objectives Describe what is meant by a drug`s
L1: Intro to Pharm- Objectives Describe what is meant by a drug`s

... Drug size: varies from very small (Li = MW 7) to very large (eg, alteplase [t-PA] = MW 59,050). Vast majority have MW between 100 & 1,000. ...
Stephen Smith Medidata Solutions Worldwide
Stephen Smith Medidata Solutions Worldwide

... “Never before have we had such a clear, crossstakeholder definition of what is wrong with drug development and what we need to do to fix it. “ Stephen Smith, Patient Advocate since 1990 ...
Introduction to Pharmacology
Introduction to Pharmacology

... • The Food & Drug Administration (FDA) approves about 30 new drugs/year • Most MDs prescribe drugs that were not known when they graduated • About 2/3 of all physician visits lead to a prescription • More than half of drug advertising $$ goes to ‘detailing’ MDs (about $5000/yr/MD) ...
Mechanisms of common and important adverse drug reactions
Mechanisms of common and important adverse drug reactions

... • Azathioprine, 6-MP detoxified by thiopurine S-methyltransferase (TPMT) • Genetic ↓ TPMT → toxicity, pancytopenia • Kits available for genotyping TPMT • Dose adjustments in pts can be life-saving ...
Western Washington University Rowing Safety
Western Washington University Rowing Safety

... This section of the departmental Safety Information Book is intended to bring Western Washington University into compliance with Washington Administrative Code (WAC), Part 29662-500 Hazardous Drugs. The University seeks to protect its employees from avoidable harm at all times and places related to ...
anti-anxiety medications
anti-anxiety medications

... What it Does: Benzodiazepines relieve anxiety and insomnia when used as prescribed. They are generally well-tolerated and have a wide margin of safety. But even when used as directed, these drugs can have dangerous side effects. The user may experience drowsiness, dizziness, and lack of coordination ...
The results of study on Unoprostone (development code UF-021) for... the 30th Annual Meeting of the Japan Society of Drug...
The results of study on Unoprostone (development code UF-021) for... the 30th Annual Meeting of the Japan Society of Drug...

... normal tension glaucoma. Since its release in 1994, it has been approved in 45 countries. In 2009 the concentration of preservative contained in Rescula® Eye Drops 0.12% was reduced by a change in the formulation, and in 2010 storage at room temperature instead of in a cold place became possible. Re ...
FDA
FDA

... • Once a drug has EU marketing authorisation, it is ‘licensed’, ‘registered’ or ‘approved’. All these terms mean the same thing. This means the company can market the drug in any EU country - but they don’t have to. For one reason or another, they may choose to market the drug in some countries but ...
Lecture Resource ()
Lecture Resource ()

... Acetylcholine is a neurohormone that enhances peristalsis, wakefulness, and memory ...
Biological Treatments for Abnormality
Biological Treatments for Abnormality

... however that do not seem to produce this effect. ...
Document
Document

... The types of drugs to be used in veterinary medicines are chemically similar to those used in humans. However, certain conditions have to be considered before deciding to use a certain drug. These include: whether treatment is economical, if there are regulatory and public health concerns, compatibi ...
PG12-23 Falasca Lay summary Principal Investigator: Professor
PG12-23 Falasca Lay summary Principal Investigator: Professor

... To develop new and more active drugs to oppose prostate cancer development and progression we need to understand which molecules are important for the tumour to grow. Once we identify these molecules, we can design drugs to block them and therefore block tumour growth. We have identified two molecul ...
Understanding Research
Understanding Research

... Understanding, and Support ...
International Journal of Modern Chemistry and Applied Science
International Journal of Modern Chemistry and Applied Science

... laboratory results in making the critical decisions of for curing different diseases. diagnonsis and treatment. Through the years, the PAIN- RELIEVING DRUGS medicines has become less of an art and more of a These are classified an analgesics or science; the hospital clinical laboratory has been at t ...
Investigational Drugs
Investigational Drugs

... After completion of phase 3 trial (safe & effective), sponsor submits NDA to the FDA requesting approval for marketing to be available to patients and physicians. ...
When Your Science Leads To - Acorda Therapeutics, Inc.
When Your Science Leads To - Acorda Therapeutics, Inc.

... We decided to work on spinal cord injuries mostly because there were no good treatments at the time we formed the company (there still aren’t), and very few companies were working in the space. Also, some major fundamental laboratory advances had been made in spinal cord injuries, and I thought the ...
< 1 ... 146 147 148 149 150 151 152 153 154 ... 161 >

Orphan drug

An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease.In the US and EU it is easier to gain marketing approval for an orphan drug, and there may be other financial incentives, such as extended exclusivity periods, all intended to encourage the development of drugs which might otherwise lack a sufficient profit motive. The assignment of orphan status to a disease and to any drugs developed to treat it is a matter of public policy in many countries, and has resulted in medical breakthroughs that may not have otherwise been achieved due to the economics of drug research and development.According to Thomson Reuters in their 2012 publication ""The Economic Power of Orphan Drugs"", there has been increased investing in orphan drug Research and Development partly due to the U. S. Orphan Drug Act (ODA) 1983 and similar Acts in other regions of the world and also driven by ""high-profile philanthropic funding."" The period between 2001 to 2011 was the ""most productive period in the history of orphan drug development, in terms of average annual orphan drug designations and orphan drug approvals."" For the same decade the compound annual growth rate (CAGR) of the orphan drugs was an ""impressive 25.8 percent, compared to only 20.1 percent for a matched control group of non-orphan drugs."" By 2012 the market for orphan drugs was worth USD$637 million compared to the USD$638 million matched control group of non-orphan drugs, Thomson Reuters.By 2012, ""the revenue-generating potential of orphan drugs [was] as great as for non-orphan drugs, even though patient populations for rare diseases are significantly smaller. Moreover, we suggest that orphan drugs have greater profitability when considered in the full context of developmental drivers including government financial incentives, smaller clinical trial sizes, shorter clinical trial times and higher rates of regulatory success.""
  • studyres.com © 2025
  • DMCA
  • Privacy
  • Terms
  • Report